InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Fraser Craig, Chairman & CEO. Officer active across 1 company, notably Windtree Therapeutics INC. Cumulatively, 12 reports have been logged. Split: 11 buys · 0 sell. Total volume traded: €32k. Activity tracked since 19 October 2021. The latest transaction was disclosed on 29 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
7,000 shares@ US$0.41540.49% mcap8.7% of flowCommon StockSEC:0001437749-22-016227:0
Ideal exit: 26 Mar 2023 (T+270)
2,000 shares@ US$0.97990.31% mcap5.6% of flowCommon StockSEC:0001437749-22-006612:0
Ideal exit: 11 Dec 2022 (T+270)
3,000 shares@ US$0.98010.47% mcap8.3% of flowCommon StockSEC:0001437749-22-006313:0
Ideal exit: 10 Dec 2022 (T+270)
166,900 shares0Common StockSEC:0001437749-22-005417:0
930 shares@ US$1.600.23% mcap4.1% of flowCommon StockSEC:0001437749-21-027198:0
Ideal exit: 16 Aug 2022 (T+270)
930 shares@ US$1.6010.5% of flowCommon StockSEC:0001437749-21-027198
Ideal exit: 16 Aug 2022 (T+270)
930 shares@ US$1.6110.6% of flowCommon StockSEC:0001437749-21-027085
Ideal exit: 15 Aug 2022 (T+270)
930 shares@ US$1.610.23% mcap4.1% of flowCommon StockSEC:0001437749-21-027085:0
Ideal exit: 15 Aug 2022 (T+270)
3,000 shares@ US$1.900.86% mcap15.2% of flowCommon StockSEC:0001437749-21-024196:0
Ideal exit: 19 Jul 2022 (T+270)
3,000 shares@ US$1.9039.3% of flowCommon StockSEC:0001437749-21-024196
Ideal exit: 19 Jul 2022 (T+270)
3,000 shares@ US$1.9139.5% of flowCommon StockSEC:0001437749-21-023910
Ideal exit: 16 Jul 2022 (T+270)
3,000 shares@ US$1.910.86% mcap15.3% of flowCommon StockSEC:0001437749-21-023910:0
Ideal exit: 16 Jul 2022 (T+270)
12 of 12 declarations
About Fraser Craig
Craig Fraser is the President and CEO of WINDTREE THERAPEUTICS INC. He leads the company's operations and oversees the implementation of its development strategy, contributing to innovation in the biotechnology sector.
